Heparin Market By Product (Weight Heparin, Unfractionated Heparin, Ultra-Low Molecular, and Low Molecular Weight Heparin), Application (Coronary Artery Disease, Atrial Fibrillation, Venous Thromboembolism, and Others), Distribution Channel (Hospital Pharmacies, Online Pharmacies, and Drug Stores & Retail Pharmacies), By Region and Companies - Industry Segment Outlook, Market Assessment, Competition Scenario, Trends, and Forecast 2023-2032
- Published date: Nov 2024
- Report ID: 15768
- Number of Pages: 377
- Format:
-
keyboard_arrow_up
-
-
- GlaxoSmithKline plc
- Aspen Pharmacare Holdings Limited
- Braun Medical Inc.
- Baxter International Inc.
- Cipla Ltd.
- Reddy's Laboratories Ltd.
- Hoffmann-La Roche Ltd.
- Fresenius SE & Co. KGaA
- Leo Pharma A/S
- Novartis AG
- Pfizer Inc.
- OPOCRIN SPA.
- Reddy's Laboratories Ltd.
- SARIA International GmbH
- Sanofi
- Teva Pharmaceutical Industries Ltd.
- United Biotech (P) Ltd.
- Viatris Inc.
- Bio-pharma Co., ltd.
- Other Key Players.
Our Clients
Kickstart 2026 with Exclusive Savings
✖
Request a Sample Report
We'll get back to you as quickly as possible